Medication information
GLP-1 medicines: approved treatment, safety checks and counterfeit-product warnings
WHO gives conditional guidance on GLP-1 therapies for adults with obesity, while FDA warns about unapproved, falsely labelled and incorrectly dosed semaglutide or tirzepatide products.
Read medication information →